全文获取类型
收费全文 | 10116篇 |
免费 | 596篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 205篇 |
妇产科学 | 185篇 |
基础医学 | 1348篇 |
口腔科学 | 452篇 |
临床医学 | 841篇 |
内科学 | 2740篇 |
皮肤病学 | 260篇 |
神经病学 | 1000篇 |
特种医学 | 382篇 |
外科学 | 1199篇 |
综合类 | 33篇 |
一般理论 | 2篇 |
预防医学 | 480篇 |
眼科学 | 137篇 |
药学 | 590篇 |
中国医学 | 27篇 |
肿瘤学 | 837篇 |
出版年
2024年 | 8篇 |
2023年 | 72篇 |
2022年 | 153篇 |
2021年 | 292篇 |
2020年 | 159篇 |
2019年 | 233篇 |
2018年 | 280篇 |
2017年 | 220篇 |
2016年 | 229篇 |
2015年 | 283篇 |
2014年 | 388篇 |
2013年 | 490篇 |
2012年 | 771篇 |
2011年 | 790篇 |
2010年 | 424篇 |
2009年 | 387篇 |
2008年 | 663篇 |
2007年 | 681篇 |
2006年 | 602篇 |
2005年 | 649篇 |
2004年 | 556篇 |
2003年 | 500篇 |
2002年 | 485篇 |
2001年 | 103篇 |
2000年 | 87篇 |
1999年 | 99篇 |
1998年 | 132篇 |
1997年 | 102篇 |
1996年 | 103篇 |
1995年 | 90篇 |
1994年 | 82篇 |
1993年 | 58篇 |
1992年 | 57篇 |
1991年 | 49篇 |
1990年 | 54篇 |
1989年 | 55篇 |
1988年 | 36篇 |
1987年 | 44篇 |
1986年 | 44篇 |
1985年 | 28篇 |
1984年 | 27篇 |
1983年 | 28篇 |
1982年 | 22篇 |
1981年 | 17篇 |
1980年 | 25篇 |
1979年 | 11篇 |
1977年 | 8篇 |
1976年 | 19篇 |
1975年 | 7篇 |
1974年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 24 毫秒
71.
Maggi F Andreoli E Lanini L Fornai C Vatteroni M Pistello M Presciuttini S Bendinelli M 《Journal of clinical microbiology》2005,43(9):4807-4810
In 239 torquetenovirus-positive people, multiple-genogroup infections were common and associated with higher viral loads than would be expected from simple additive effects. The latter observation was restricted to the infections which included both genogroups 1 and 3, pointing to the possible existence of some kind of infection facilitation between these genogroups. 相似文献
72.
Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors 下载免费PDF全文
Zacchigna S Papa G Antonini A Novati F Moimas S Carrer A Arsic N Zentilin L Visintini V Pascone M Giacca M 《The American journal of pathology》2005,167(4):981-991
A major challenge in reconstructive surgery is flap ischemia, which might benefit from induction of therapeutic angiogenesis. Here we demonstrate the effect of an adeno-associated virus (AAV) vector delivering vascular endothelial growth factor (VEGF)165 in two widely recognized in vivo flap models. For the epigastric flap model, animals were injected subcutaneously with 1.5 x 10(11) particles of AAV-VEGF at day 0, 7, or 14 before flap dissection. In the transverse rectus abdominis musculocutaneous flap model, AAV-VEGF was injected intramuscularly. The delivery of AAV-VEGF significantly improved flap survival in both models, reducing necrosis in all treatment groups compared to controls. The most notable results were obtained by administering the vector 14 days before flap dissection. In the transverse rectus abdominis musculocutaneous flap model, AAV-VEGF reduced the necrotic area by >50% at 1 week after surgery, with a highly significant improvement in the healing process throughout the following 2 weeks. The therapeutic effect of AAV-VEGF on flap survival was confirmed by histological evidence of neoangiogenesis in the formation of large numbers of CD31-positive capillaries and alpha-smooth muscle actin-positive arteriolae, particularly evident at the border between viable and necrotic tissue. These results underscore the efficacy of VEGF-induced neovascularization for the prevention of tissue ischemia and the improvement of flap survival in reconstructive surgery. 相似文献
73.
Neoplastic cells generally present profound changes in glucose metabolism. The mechanisms underlying such process are numerous and all may involve altered cellular hormonal responses. Here we report the first evidence that cellular location of phosphofructokinase activity in human breast cancer tissues is different from the one observed in control tissues and that this phenomenon may be involved in the increased glycolytic flux observed in those cells. Through co-sedimentation techniques, we observed that 60% of phosphofructokinase activity in neoplastic tissues is located in an actin-enriched fraction, against 36% in control tissues. Additionally, metastatic tumor tissues presented a two fold increase in this particulate activity when compared to non-metastatic tumor samples. We propose that the alteration in cellular distribution of phosphofructokinase activity in human breast cancer tissues is a mechanism associated to the process of cell transformation and may be a consequence of the altered hormonal milieu observed in several types of cancer. 相似文献
74.
75.
Costa-Mattioli M Allavena C Poirier AS Billaudel S Raffi F Ferré V 《Journal of medical virology》2002,68(1):7-11
Hepatitis A virus (HAV) is a worldwide disease; in most cases, it causes an acute self-limited illness that does not lead to a chronic state. The course of HAV viremia in a homosexual male with human immunodeficiency virus type 1 (HIV-1) and the correlation between HIV and HAV viral load, alanine aminotranferase (ALT) level, and CD4(+) lymphocyte count were investigated during the course of the infection. HAV RNA was detected quantitatively up to 256 days after clinical onset. To our knowledge, this specific case is the first report of a prolonged infection with hepatitis A in a male with HIV-1. The ALT levels decreased gradually; however, 286 days after clinical onset of hepatitis, ALT levels were three times higher than normal values. HIV viral load was not affected by the infection with HAV and CD4(+) cell count was stable during the course of the co-infection. The duration and the high-titer viremia of hepatitis A virus in an immunodeficient patient constitute a serious risk of the spread of hepatitis A within this population. As inactivated HAV vaccine is safe in HIV-positive subjects, it would be wise to establish a strategy of preventive vaccination in this high-risk group. 相似文献
76.
Alkylating agents are a structurally diverse group of compounds that cause a wide range of biological effects, including cell death, mutation and cancer. DNA damaged by these agents contains widely different amounts of 12 alkylated purines/pyrimidines and two phosphotriester isomers. The biological effects appear to be mediated predominantly by attack at the O(6) position of guanine. DNA extracted from various normal human tissues contains detectable levels of O(6)-alkylguanine, the source of which has not been defined. Given that, following DNA replication, this lesion cannot only generate point mutations but can also initiate mismatch repair-mediated DNA recombination and cell death, it seems worthwhile to consider the possible contribution of these events and cell killing to the aetiology of human cancer. There is increasing evidence that point mutations are not the only mechanism involved in malignant transformation by alkylating agents. Some cancer chemotherapeutic agents exploit the cytotoxic effects of O(6)-alkylguanine and an understanding of the processing of this lesion has allowed strategies to be developed that should increase the effectiveness of such agents. 相似文献
77.
Paolo Sportoletti Beatrice Del Papa Mariangela De Ioanni Lorenzo Moretti Elisabetta Bonifacio Vania Lanterna Alain Bell Katia Fettucciari Eugenia Carnevali Tiziana Zei Franca Falzetti Massimo F Martelli Antonio Tabilio Mauro Di Ianni 《Biology of blood and marrow transplantation》2006,12(12):1250-1260
T-cell homeostasis is regulated by several molecules; among these, interleukin (IL)-7 plays an essential role in the survival and homeostatic proliferation of peripheral naive T cells. In a previous study, we investigated whether human mesenchymal stromal cells (MSCs) could be engineered with the IL-7 gene to produce functional level of this cytokine. In the present study, we analyzed the impact of different quantities of IL-7 produced by MSCs on the survival and proliferation of a negative immunoselected naive (CD3(+)/CD45RA(+)) T-cell population. Co-cultivation of peripheral naive T cells with MSCs producing low (16 pg/mL) or high (1000 pg/mL) IL-7 levels or in the presence of exogenous IL-7 (0.01 ng/mL and 100 ng/mL) maintained the CD3(+)/CD45RA(+) naive T-cell phenotype. Chemokine receptor CCR7(+) expression was also maintained among this T-cell population. Naive T-cell molecular characteristics were maintained as assessed by the Vbeta spectratyping complexity score, which showed the maintenance of a broad T-cell repertoire. No Th1 or Th2 differentiation was observed, as assessed by interferon-gamma or IL-4 accumulation. In contrast, only MSCs producing high amounts of IL-7 caused increased activation (CD25 31.2% +/- 12% vs 10% +/- 3.5%; P < .05), proliferation (CD71 17.8+/-7% vs 9.3%+/-3, P < .05), apoptosis (assessed by annexin V: 18.6% +/- 5% vs 14.9% +/- 2.6%; P > .05), and the phase S cell cycle (15% vs 6.9%, P > .05). Exogenous IL-7 exhibited no significant effect. In conclusion, we demonstrated that IL-7 produced by MSCs has a dose-independent effect on naive T-cell survival while exerting a dose-dependent effect on activation/proliferation. Due to the continuous production of IL-7 by engineered cells, our system is more efficacious than exogenous IL-7. 相似文献
78.
79.
80.
Barbaro G Grisorio B Fruttaldo L Bacca D Babudieri S Torre D Francavilla R Rizzo G Belloni G Lucchini A Annese M Matarazzo F Hazra C Barbarini G 《BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy》2003,17(6):433-439
Background: The differential tolerability profile of various interferon (IFN)-α preparations used in combination with ribavirin for the treatment of chronic hepatitis C needs to be elucidated. Approximately 8% of patients receiving recombinant IFNα-2b plus ribavirin discontinue treatment because of adverse events. Human leucocyte IFNα is deemed to have a better safety profile than recombinant IFNα. We therefore compared the safety profile and efficacy of ribavirin combined with leucocyte IFNα or with recombinant IFNα-2b in treatment-naive patients with chronic hepatitis C. Study design: We randomised 423 patients to either leucocyte IFNα 3MU three times weekly plus ribavirin (210 patients) or the same dose of recombinant IFNα-2b plus ribavirin (213 patients). Patients were treated for 24 weeks and followed-up for a further 48 weeks. The primary endpoint was the safety profile of the two therapies; the secondary endpoint was the rate of sustained response. Results: In patients receiving leucocyte IFNα, the total number of adverse events was lower than in the group receiving recombinant IFNα (259 vs 441 patients), and the percentage of patients discontinuing treatment because of adverse events or laboratory abnormalities was significantly reduced (4% vs 11%; p = 0.013). Sustained response was observed in 47% of patients receiving leucocyte IFNα plus ribavirin and in 44% of patients receiving IFNα-2b plus ribavirin. Conclusions: Both therapeutic regimens were effective in inducing a sustained response in naive patients. However, the safety profile of leucocyte IFNα plus ribavirin was more favourable than that observed with the administration of recombinant IFNα-2b plus ribavirin, suggesting that leucocyte IFNα may be an alternative option in patients with reduced tolerability to other IFNs. 相似文献